A carregar...

HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice

HER2 is overexpressed in approximately 10%-20% of gastric and gastroesophageal junction carcinomas. In these types of cancer, accurate assessment of HER2 status is mandatory, for selecting patients who may benefit from targeted therapies with anti-HER2 drugs such as Trastuzumab. This manuscript focu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Grillo, Federica, Fassan, Matteo, Sarocchi, Francesca, Fiocca, Roberto, Mastracci, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4948273/
https://ncbi.nlm.nih.gov/pubmed/27468182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i26.5879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!